跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vaxneuvance - SFDA Drug Approval Details
Approvals
/
SFDA
/
Vaxneuvance
Authorized
BIOLOGICAL
Vaxneuvance
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
945c9d9d76eb13c0
Company
Unknown
Type
Biological
Approval Details
Approval Id
945c9d9d76eb13c0
Drug Approval Sfda Name
Vaxneuvance
Trade Name
Vaxneuvance
Generic Name
Pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)
Register Number
2208234020
Register Year
2023
Drug Type
Biological
Route Of Administration
Intramuscular use
Package Type
Pre-filled syringe
Package Size
1
Size
0.5
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000002674-64-200000016499
Price
270.45
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
945c9d9d76eb13c0
Type
Biological
Back to SFDA Approvals